No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 958 | 1,122 | 1,412 | 1,631 | 1,838 | 2,088 | N/A | N/A |
| Operating profit | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | $m | 89 | 115 | 143 | 185 | 198 | 251 | N/A | N/A |
| EPS reported | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | Locked | Locked | Locked |
| Environmental score | Locked | Locked | Locked |
| Social score | Locked | Locked | Locked |
| Governance score | Locked | Locked | Locked |
| Risk rating | Locked | Locked | Locked |
Company overview
ExlService Holdings, Inc. functions as a global provider of data analytics, digital operational solutions, and comprehensive services, operating across the United States and internationally. The company organizes its operations into distinct segments: Insurance, Healthcare, Analytics, and Emerging Business. For the insurance sector, EXL delivers a suite of digital transformation and analytics-driven services. These offerings span a wide array of functions, including streamlined claims processing, administration of premiums and benefits, agency oversight, account reconciliation, policy research, underwriting assistance, new client acquisition, policy servicing, premium audits, various surveys (including commercial and residential), invoicing and collections, and enhanced customer support. These services are powered by cutting-edge digital technologies, artificial intelligence, machine learning, and sophisticated automation. Furthermore, EXL facilitates digital customer acquisition through a Software-as-a-Service (SaaS) model via its LifePRO and LISS platforms, and also provides subrogation services, including its comprehensive Subrosource software platform. In the healthcare domain, EXL presents CareRadius, an integrated care management system. It delivers diverse healthcare services such as care management, utilization review, disease management, payment accuracy, revenue enhancement, and customer interaction strategies for healthcare payers, service providers, pharmacy benefit management companies, and life sciences entities. Beyond these industry-specific services, EXL specializes in advanced predictive and prescriptive analytical capabilities. These are applied to critical areas like customer acquisition and lifecycle navigation, risk assessment and pricing, optimizing operational efficiency, oversight of credit and operational risks, ensuring payment accuracy and care coordination, and comprehensive data governance. Established in 1999, ExlService Holdings, Inc. maintains its corporate headquarters in New York, New York.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
ExlService Holdings, Inc. functions as a global provider of data analytics, digital operational solutions, and comprehensive services, operating across the United States and internationally. The company organizes its operations into distinct segments: Insurance, Healthcare, Analytics, and Emerging Business. For the insurance sector, EXL delivers a suite of digital transformation and analytics-driven services. These offerings span a wide array of functions, including streamlined claims processing, administration of premiums and benefits, agency oversight, account reconciliation, policy research, underwriting assistance, new client acquisition, policy servicing, premium audits, various surveys (including commercial and residential), invoicing and collections, and enhanced customer support. These services are powered by cutting-edge digital technologies, artificial intelligence, machine learning, and sophisticated automation. Furthermore, EXL facilitates digital customer acquisition through a Software-as-a-Service (SaaS) model via its LifePRO and LISS platforms, and also provides subrogation services, including its comprehensive Subrosource software platform. In the healthcare domain, EXL presents CareRadius, an integrated care management system. It delivers diverse healthcare services such as care management, utilization review, disease management, payment accuracy, revenue enhancement, and customer interaction strategies for healthcare payers, service providers, pharmacy benefit management companies, and life sciences entities. Beyond these industry-specific services, EXL specializes in advanced predictive and prescriptive analytical capabilities. These are applied to critical areas like customer acquisition and lifecycle navigation, risk assessment and pricing, optimizing operational efficiency, oversight of credit and operational risks, ensuring payment accuracy and care coordination, and comprehensive data governance. Established in 1999, ExlService Holdings, Inc. maintains its corporate headquarters in New York, New York.